GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (XSWX:DOCM) » Definitions » Earnings per Share (Diluted)

DocMorris AG (XSWX:DOCM) Earnings per Share (Diluted) : CHF7.05 (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG Earnings per Share (Diluted)?

DocMorris AG's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was CHF-5.07. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF7.05.

DocMorris AG's EPS (Basic) for the six months ended in Dec. 2023 was CHF-5.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF7.05.

DocMorris AG's EPS without NRI for the six months ended in Dec. 2023 was CHF-5.09. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-10.07.

During the past 3 years, the average EPS without NRIGrowth Rate was 11.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -16.80% per year.

During the past 13 years, DocMorris AG's highest 3-Year average EPS without NRI Growth Rate was 11.30% per year. The lowest was -55.90% per year. And the median was -29.20% per year.


DocMorris AG Earnings per Share (Diluted) Historical Data

The historical data trend for DocMorris AG's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocMorris AG Earnings per Share (Diluted) Chart

DocMorris AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.04 -14.95 -23.40 -15.88 7.05

DocMorris AG Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.37 -8.29 -7.59 12.12 -5.07

Competitive Comparison of DocMorris AG's Earnings per Share (Diluted)

For the Pharmaceutical Retailers subindustry, DocMorris AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocMorris AG's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where DocMorris AG's PE Ratio falls into.



DocMorris AG Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

DocMorris AG's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(82.28-0)/11.674
=7.05

DocMorris AG's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-59.325-0)/11.664
=-5.09

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF7.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


DocMorris AG  (XSWX:DOCM) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


DocMorris AG Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of DocMorris AG's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


DocMorris AG (XSWX:DOCM) Business Description

Traded in Other Exchanges
Address
Walzmuhlestrasse 60, Frauenfeld, CHE, 8500
DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.

DocMorris AG (XSWX:DOCM) Headlines

No Headlines